Notice of NHLBI Participation in PAR-22-151 Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
Notice Number:
NOT-HL-24-073

Key Dates

Release Date:

January 25, 2025

Related Announcements

  • April 21, 2022 - Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional). See NOFO PAR-22-151.

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the NHLBI is participating, effective immediately, in PAR-22-151 Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)


The following text (shown in italics) has been added to reflect NHLBI's participation in this NOFO:

Part 1. Overview Information

Components of Participating Organizations

National Heart, Lung, and Blood Institute (NHLBI

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.837, 93.838, 93.839, 93.840, 93.233 

Part 2. Section I. Funding Opportunity Description

The following information has been added:

Specific Interests of the National Heart, Lung, and Blood Institute (NHLBI)

The National Heart, Lung, and Blood Institute (NHLBI) is interested in training programs that sustainably strengthen the HIV-associated heart, lung, blood, and sleep (HLBS) research capacity of low- and middle-income country (LMIC) institutions; train in-country experts to develop and conduct research to strengthen the HIV research capacity at the proposed LMIC institutions related to HIV-associated HLBS diseases and disorders; and maximize NHLBI’s current global health investments, with the long-range goal of developing and implementing evidence-based, contextualized HIV-associated HLBS interventions to reduce the burden of chronic diseases. Multidisciplinary Training programs across the spectrum of research disciplines is encouraged, from basic biomedical, behavioral, and social science to clinical and applied sciences, including translational and implementation science that support evidence integration and emphasize the resources, context, and needs of multiple stakeholders in local settings. Training programs should include basic research skills, research design and methodology, ethics, data management and analysis, grant writing, manuscript writing, scientific presentations, as well as research administration and execution.

Examples of Research training programs include those that advance clinical translational research in understudied conditions, or those that grow capacity in new approaches to research. These include but are not limited to:

  • Research training programs to improve HIV-related cardiovascular, pulmonary, hematologic sciences and transfusion medicine or sleep health 
  • Research training programs identifying prevention, screening, and/or treatment approaches to reduce HLBS disease burden in HIV-infected individuals across the lifespan 
  • Research training programs examining basic, epidemiologic, clinical, behavioral, and/or social science questions, related to HIV- and ART-associated HLBS risk factors in adults and aging population to curtail disease progression
  • Research training programs deciphering the pathophysiology and mechanisms of disease progression related to HIV-associated HLBS disorders
  • Research training programs focused on community-based research related to HIV-associated HLBS risk factors in vulnerable communities using complex/multi-component interventions, structural interventions, comparative effectiveness, impact evaluation or health economics models
  • Research training programs focused on dissemination and implementation science, to improve the prevention, care and treatment for HIV-associated HLBS complications
  • Research training programs developing cross-disciplinary HIV-associated HLBS studies among vulnerable or under-researched LMIC populations, including women, substance (drug and alcohol) users, men who have sex with men, transgendered populations, aging populations, orphans, and children
  • Research training programs focused on data science, biostatistics and bioinformatics capacity to drive clinical translational research in HIV associated HLBS conditions (e.g., data analysis, data management, and data quality assurance and control)

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

Mary Masterson, PhD, MS
National Heart, Lung, and Blood Institute (NHLBI)
Center for Translation Research and Implementation Science (CTRIS)
Telephone: 301-827-6113  
Email: Mary.Masterson@nih.gov

Makeda Williams, PhD, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Center for Translation Research and Implementation Science (CTRIS)
Telephone: 301-451-7594  
Email: makeda.williams@nih.gov

Financial/Grants Management Contact(s)

Fatima Kamara
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-7196  
Email: fatima.kamara@nih.gov

 

Inquiries

Please direct all inquiries to:

Mary Masterson PhD, MS
National Heart, Lung, and Blood Institute (NHLBI)
Center for Translation Research and Implementation Science (CTRIS)
Telephone: 301-827-6113  
Email: Mary.Masterson@nih.gov